Skip to content

HBIO

HARVARD BIOSCIENCE INC

NASDAQ · Healthcare · Medical - Instruments & Supplies · US

$8.61
−0.69%
Ask drillr
Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open
$8.85
From 52W high
−3.26%
Volume
9981.00
Market cap
$39.20M
P/E (Fwd)
13.2x
EV/EBITDA
−43.9x
P/E (TTM)
—
RSI (14)
57.5
1D Return
−0.69%
YTD Return
+28.55%
SummaryUpdated Jun 1, 2026

Harvard Bioscience, Inc. (NASDAQ:HBIO) is a Massachusetts-based company founded in 1901 that develops, manufactures, and sells specialized scientific instruments and technologies for life sciences research. Originally established as Harvard Apparatus, the company has evolved over more than a century from a small scientific instrument maker into a publicly traded corporation serving the global research community. Today, Harvard Bioscience operates as a niche player in the scientific instrumentation market, providing essential tools that enable fundamental research, drug discovery, and preclinical testing across pharmaceutical companies, biotechnology firms, universities, and government laboratories worldwide.

Similar companies

Latest newsMore news →